Elior Group Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Elior Group wird ein jährliches Gewinn- und Umsatzwachstum von 109.5% bzw. 3.5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 113.8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 10.4% betragen.

Wichtige Informationen

109.5%

Wachstumsrate der Gewinne

113.8%

EPS-Wachstumsrate

Hospitality Gewinnwachstum10.6%
Wachstumsrate der Einnahmen3.5%
Zukünftige Eigenkapitalrendite10.4%
Analystenabdeckung

Good

Zuletzt aktualisiert21 May 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Is Elior Group (EPA:ELIOR) Using Too Much Debt?

Jun 17
Is Elior Group (EPA:ELIOR) Using Too Much Debt?

Elior Group SA (EPA:ELIOR) Shares Fly 63% But Investors Aren't Buying For Growth

May 21
Elior Group SA (EPA:ELIOR) Shares Fly 63% But Investors Aren't Buying For Growth

Elior Group (EPA:ELIOR) Use Of Debt Could Be Considered Risky

Feb 29
Elior Group (EPA:ELIOR) Use Of Debt Could Be Considered Risky

A Piece Of The Puzzle Missing From Elior Group SA's (EPA:ELIOR) 30% Share Price Climb

Dec 22
A Piece Of The Puzzle Missing From Elior Group SA's (EPA:ELIOR) 30% Share Price Climb

Slammed 25% Elior Group SA (EPA:ELIOR) Screens Well Here But There Might Be A Catch

Aug 20
Slammed 25% Elior Group SA (EPA:ELIOR) Screens Well Here But There Might Be A Catch

Health Check: How Prudently Does Elior Group (EPA:ELIOR) Use Debt?

Jan 05
Health Check: How Prudently Does Elior Group (EPA:ELIOR) Use Debt?

Elior Group SA (EPA:ELIOR) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Nov 26
Elior Group SA (EPA:ELIOR) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Does Elior Group (EPA:ELIOR) Have A Healthy Balance Sheet?

Jul 28
Does Elior Group (EPA:ELIOR) Have A Healthy Balance Sheet?

Is Elior Group (EPA:ELIOR) Using Too Much Debt?

Jan 04
Is Elior Group (EPA:ELIOR) Using Too Much Debt?

Elior Group SA (EPA:ELIOR) Shares Could Be 44% Below Their Intrinsic Value Estimate

Oct 20
Elior Group SA (EPA:ELIOR) Shares Could Be 44% Below Their Intrinsic Value Estimate

Health Check: How Prudently Does Elior Group (EPA:ELIOR) Use Debt?

Sep 15
Health Check: How Prudently Does Elior Group (EPA:ELIOR) Use Debt?

Is Elior Group (EPA:ELIOR) Using Debt Sensibly?

Jun 12
Is Elior Group (EPA:ELIOR) Using Debt Sensibly?

A Look At The Fair Value Of Elior Group SA (EPA:ELIOR)

May 22
A Look At The Fair Value Of Elior Group SA (EPA:ELIOR)

What Does Elior Group SA's (EPA:ELIOR) Share Price Indicate?

Mar 23
What Does Elior Group SA's (EPA:ELIOR) Share Price Indicate?

What Kind Of Shareholders Hold The Majority In Elior Group SA's (EPA:ELIOR) Shares?

Mar 02
What Kind Of Shareholders Hold The Majority In Elior Group SA's (EPA:ELIOR) Shares?

Calculating The Fair Value Of Elior Group SA (EPA:ELIOR)

Feb 09
Calculating The Fair Value Of Elior Group SA (EPA:ELIOR)

Does Elior Group (EPA:ELIOR) Have A Healthy Balance Sheet?

Jan 18
Does Elior Group (EPA:ELIOR) Have A Healthy Balance Sheet?

If You Had Bought Elior Group's (EPA:ELIOR) Shares Five Years Ago You Would Be Down 70%

Dec 29
If You Had Bought Elior Group's (EPA:ELIOR) Shares Five Years Ago You Would Be Down 70%

What Does Elior Group S.A.'s (EPA:ELIOR) Share Price Indicate?

Dec 07
What Does Elior Group S.A.'s (EPA:ELIOR) Share Price Indicate?

Gewinn- und Umsatzwachstumsprognosen

ENXTPA:ELIOR - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
9/30/20266,5309721633410
9/30/20256,2867514728710
9/30/20246,05771782798
3/31/20245,868-69114208N/A
12/31/20235,546-8127115N/A
9/30/20235,223-93-6122N/A
3/31/20234,690-184-3632N/A
12/31/20224,571-305-70-2N/A
9/30/20224,451-427-104-36N/A
3/31/20224,060-330-124-52N/A
12/31/20213,875-222-76-6N/A
9/30/20213,690-114-2940N/A
6/30/20213,534-306-73-1N/A
3/31/20213,377-499-116-41N/A
12/31/20203,672-472-109-23N/A
9/30/20203,967-446-103-5N/A
6/30/20204,378-203N/AN/AN/A
3/31/20204,788391,4821,595N/A
12/31/20194,856541,4371,553N/A
9/30/20194,923691,3911,511N/A
6/30/20194,92010N/AN/AN/A
3/31/20194,916-5081213N/A
12/31/20184,901-3962211N/A
9/30/20184,886-2942209N/A
6/30/20185,3294048260N/A
3/31/20185,77311053311N/A
12/31/20176,097112N/A338N/A
9/30/20176,422115N/A365N/A
6/30/20176,305136N/A355N/A
3/31/20176,189157N/A345N/A
12/31/20166,019143N/A349N/A
9/30/20165,896142N/A275N/A
6/30/20165,802133N/A289N/A
3/31/20165,772111N/A280N/A
12/31/20155,738116N/A285N/A
9/30/20155,674107N/A294N/A
6/30/20155,58195N/A269N/A
3/31/20155,49267N/A217N/A
12/31/20145,41262N/A211N/A
9/30/20145,34148N/A241N/A
6/30/20145,286-16N/A215N/A
3/31/20145,243-9N/A227N/A
12/31/20135,118-5N/A166N/A
9/30/20135,0179N/A161N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: ELIOR wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (1.1%).

Ertrag vs. Markt: ELIOR wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.

Hohe Wachstumserträge: ELIOR wird voraussichtlich in den nächsten 3 Jahren rentabel werden.

Einnahmen vs. Markt: ELIORDie Einnahmen des Unternehmens (3.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt French (5.8% pro Jahr).

Hohe Wachstumseinnahmen: ELIORDie Einnahmen des Unternehmens (3.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: ELIORDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (10.4%).


Wachstumsunternehmen entdecken